A glance at what’s happening in the world of technology - Winter 2023.
Gene therapy for Stargardt disease in the offing
Scientists at the National Eye Institute have found the first direct evidence that Stargardt-related ABCA4 gene mutations affect the retinal pigment epithelium (RPE).
The discovery points to a new understanding of the progression of this rare inherited blinding disease and suggests a therapeutic strategy. The research team used a new stem cell-based model made from skin cells, according to the study published in Stem Cell Reports.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
The Government’s 10-Year Health Plan is a crucial chance to expand and strengthen primary eye care by cutting hospital pressure and tackling inequalities in access across England.
New cross-sector Eye Care Interoperability Steering Group has been formed to spearhead the development and implementation of common standards for eye care images in the UK.